Stage 4S Neuroblastoma Completed Phase 1 Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0029574 (Stage 4S Neuroblastoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01208454Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent NeuroblastomaTreatment